Session date: 
Wednesday, July 18, 2018 - 7:30am to 8:30am
HUB for Collaborative Medicine Building
8701 W. Watertown Plank Road
Conference Room A6520, 6th floor
Milwaukee, WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Program Description: 

This educational activity is designed to enhance the knowledge of the academic and community dermatologists who attend our weekly meeting.  Live patients are invited to grand rounds who demonstrate key points in patient diagnosis management and will emphasize application of evidence-based medicine.  Speaker topics will be chosen based on Grand Rounds quarterly evaluations as well as Wisconsin Dermatological Society evaluations where attendees were asked "What clinical questions or patient problems did you encounter in the past year that you felt you needed more knowledge or competence to successfully address?”.

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement: 
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of  Participation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals. 

Target audience: 

Allied Health Care Professionals

Learning objectives: 
  • Understand recent advances in the pathogenesis, epidemiology, and burden of dermatitis.
  • Understand the evidence for different topical and systemic therapeutic options in atopic dermatitis, particularly moderate-severe disease.
  • Design a program for management of the cutaneous and systemic manifestations of moderate-severe atopic dermatitis.
Faculty & credentials: 

Activity Director: Yvonne Chiu, MD

All persons in control of content have NO relevant financial relationships to disclose with the exception of:

Jonathan Silverberg, MD, PhD

Consult  for - 
Abbvie, Anaptysbio, Asana, Eli Lilly, Galderma, Glenmark, Kiniksa, Leo, Menlo, Pfizer, Realm, Regeneron-Sanofi, Roivant

Investigator for -
Abbvie, Celgene, Chugai, Galderma, GlaxoSmithKline, Eli Lilly, Kiniksa, Leo, Realm, Roche-Hoffman, Regeneron-Sanofi

Speaker for - 


Shelly Martin
Phone number: 
+1 (414) 955-3106